Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-05

Clinical Trial Update: Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department [Phase 3]

View source ↗

Summary

Clinical trial update for intranasal lidocaine to treat pediatric migraine in the emergency department in Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal lidocaine (lidocaine)

Snippet

Sponsor: New York City Health and Hospitals Corporation | Conditions: Migraine | Phase 3 | Status: UNKNOWN